Figure 3
Sorafenib and everolimus effect on (A) ERM activation and (B) MES-MM98 cell migration; black line untreated cells, blue line everolimus 10nM, green line sorefenib 2.5 μM, and red line combination-treated cells.
Figure 3 | BMC Cancer
